Cargando…

Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS

Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely underst...

Descripción completa

Detalles Bibliográficos
Autores principales: Ochi, Tsunehiro, Kawaguchi, Takumi, Nakahara, Takashi, Ono, Masafumi, Noguchi, Shuhei, Koshiyama, Yuichi, Munekage, Kensuke, Murakami, Eisuke, Hiramatsu, Akira, Ogasawara, Mitsunari, Hirose, Akira, Mizuta, Hiroshi, Masuda, Kosei, Okamoto, Nobuto, Suganuma, Narufumi, Chayama, Kazuaki, Yamaguchi, Masahiro, Torimura, Takuji, Saibara, Toshiji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579047/
https://www.ncbi.nlm.nih.gov/pubmed/28860506
http://dx.doi.org/10.1038/s41598-017-09256-4
_version_ 1783260627627671552
author Ochi, Tsunehiro
Kawaguchi, Takumi
Nakahara, Takashi
Ono, Masafumi
Noguchi, Shuhei
Koshiyama, Yuichi
Munekage, Kensuke
Murakami, Eisuke
Hiramatsu, Akira
Ogasawara, Mitsunari
Hirose, Akira
Mizuta, Hiroshi
Masuda, Kosei
Okamoto, Nobuto
Suganuma, Narufumi
Chayama, Kazuaki
Yamaguchi, Masahiro
Torimura, Takuji
Saibara, Toshiji
author_facet Ochi, Tsunehiro
Kawaguchi, Takumi
Nakahara, Takashi
Ono, Masafumi
Noguchi, Shuhei
Koshiyama, Yuichi
Munekage, Kensuke
Murakami, Eisuke
Hiramatsu, Akira
Ogasawara, Mitsunari
Hirose, Akira
Mizuta, Hiroshi
Masuda, Kosei
Okamoto, Nobuto
Suganuma, Narufumi
Chayama, Kazuaki
Yamaguchi, Masahiro
Torimura, Takuji
Saibara, Toshiji
author_sort Ochi, Tsunehiro
collection PubMed
description Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely understood. To clarify these differences, patients with NAFLD (n = 37) and C-CH (n = 40) were evaluated with a continuous glucose monitoring system (CGMS). In the patients with NAFLD, Maximum blood glucose concentration and blood glucose swings were significantly correlated with hepatic fibrosis markers. In the patients with C-CH, however, those two CGMS parameters were negatively correlated with the serum albumin (ALB) concentration. Furthermore, in the patients with C-CH with an ALB concentration of ≤4.0 g/dl, those two CGMS parameters were negatively correlated with the ALB concentration with greater statistical significance. In conclusion, obvious differences in the characteristics of glucose intolerance between patients with NAFLD and those with C-CH were clarified. In patients with NAFLD, glucose intolerance gradually progressed in accordance with the progression of hepatic fibrosis. In those with C-CH, glucose intolerance suddenly developed upon the appearance of hypoalbuminaemia.
format Online
Article
Text
id pubmed-5579047
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-55790472017-09-06 Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS Ochi, Tsunehiro Kawaguchi, Takumi Nakahara, Takashi Ono, Masafumi Noguchi, Shuhei Koshiyama, Yuichi Munekage, Kensuke Murakami, Eisuke Hiramatsu, Akira Ogasawara, Mitsunari Hirose, Akira Mizuta, Hiroshi Masuda, Kosei Okamoto, Nobuto Suganuma, Narufumi Chayama, Kazuaki Yamaguchi, Masahiro Torimura, Takuji Saibara, Toshiji Sci Rep Article Glucose intolerance frequently develops in accordance with the progression of chronic liver disease. However, differences in the characteristics of glucose intolerance between patients with nonalcoholic fatty liver disease (NAFLD) and those with chronic hepatitis C (C-CH) remain incompletely understood. To clarify these differences, patients with NAFLD (n = 37) and C-CH (n = 40) were evaluated with a continuous glucose monitoring system (CGMS). In the patients with NAFLD, Maximum blood glucose concentration and blood glucose swings were significantly correlated with hepatic fibrosis markers. In the patients with C-CH, however, those two CGMS parameters were negatively correlated with the serum albumin (ALB) concentration. Furthermore, in the patients with C-CH with an ALB concentration of ≤4.0 g/dl, those two CGMS parameters were negatively correlated with the ALB concentration with greater statistical significance. In conclusion, obvious differences in the characteristics of glucose intolerance between patients with NAFLD and those with C-CH were clarified. In patients with NAFLD, glucose intolerance gradually progressed in accordance with the progression of hepatic fibrosis. In those with C-CH, glucose intolerance suddenly developed upon the appearance of hypoalbuminaemia. Nature Publishing Group UK 2017-08-31 /pmc/articles/PMC5579047/ /pubmed/28860506 http://dx.doi.org/10.1038/s41598-017-09256-4 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Ochi, Tsunehiro
Kawaguchi, Takumi
Nakahara, Takashi
Ono, Masafumi
Noguchi, Shuhei
Koshiyama, Yuichi
Munekage, Kensuke
Murakami, Eisuke
Hiramatsu, Akira
Ogasawara, Mitsunari
Hirose, Akira
Mizuta, Hiroshi
Masuda, Kosei
Okamoto, Nobuto
Suganuma, Narufumi
Chayama, Kazuaki
Yamaguchi, Masahiro
Torimura, Takuji
Saibara, Toshiji
Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
title Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
title_full Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
title_fullStr Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
title_full_unstemmed Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
title_short Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS
title_sort differences in characteristics of glucose intolerance between patients with nafld and chronic hepatitis c as determined by cgms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5579047/
https://www.ncbi.nlm.nih.gov/pubmed/28860506
http://dx.doi.org/10.1038/s41598-017-09256-4
work_keys_str_mv AT ochitsunehiro differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT kawaguchitakumi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT nakaharatakashi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT onomasafumi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT noguchishuhei differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT koshiyamayuichi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT munekagekensuke differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT murakamieisuke differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT hiramatsuakira differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT ogasawaramitsunari differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT hiroseakira differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT mizutahiroshi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT masudakosei differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT okamotonobuto differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT suganumanarufumi differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT chayamakazuaki differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT yamaguchimasahiro differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT torimuratakuji differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms
AT saibaratoshiji differencesincharacteristicsofglucoseintolerancebetweenpatientswithnafldandchronichepatitiscasdeterminedbycgms